Disease-modifying drug reduces brain protein plaques in Alzheimer patients

Madely Health Headlines Commentary for March 1, 2010

Source:

Neuroimaging technique shows potential of bapineuzumab treatment and might be useful in assessing other drugs for Alzheimer’s Disease

Reference:

11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer’s disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

Send a Comment

Bitnami